Home › Trial NCT01174940
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease
- Trial IDNCT01174940
- StatusCompleted
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorUniversity of Kansas Medical Center
- Enrollment22
- Start date2010-06
- ConditionsStem Cell Leukemia of Unclear Lineage · Graft Versus Host Disease
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.